This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Biochemicals
FREE Shipping
CJC-1295 NO DAC
$
169 AUD
$169
Product description
CJC-1295 (No DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) used in laboratory and biochemical research. Unlike DAC-modified variants, the No DAC form has a shorter active profile, making it suitable for studies examining pulsatile growth hormone signalling and receptor interaction. It is commonly utilised in controlled research settings focused on endocrine pathways, hormone regulation, and peptide–receptor dynamics. This compound is supplied strictly for research purposes only and is not intended for human or veterinary use.
Product description
CJC-1295 (No DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) used in laboratory and biochemical research. Unlike DAC-modified variants, the No DAC form has a shorter active profile, making it suitable for studies examining pulsatile growth hormone signalling and receptor interaction. It is commonly utilised in controlled research settings focused on endocrine pathways, hormone regulation, and peptide–receptor dynamics. This compound is supplied strictly for research purposes only and is not intended for human or veterinary use.
Product description
CJC-1295 (No DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) used in laboratory and biochemical research. Unlike DAC-modified variants, the No DAC form has a shorter active profile, making it suitable for studies examining pulsatile growth hormone signalling and receptor interaction. It is commonly utilised in controlled research settings focused on endocrine pathways, hormone regulation, and peptide–receptor dynamics. This compound is supplied strictly for research purposes only and is not intended for human or veterinary use.
Buy 5 and save 4%
AUD169
$
Buy 10 and save 8%
AUD169
$
Categories
Gut Inflammation BPC-157, KPV, Larazotide (60 Capsules)
Longevity, Performance & Obesity Research (60 Capsules)
Methylene Blue 10mg (60 Capsules)
NMN 500mg (60 Capsules)
O-304 100mg (30 Capsules)
Repair and Recovery Research
BPC157, Thymosin β4 Fragment
Tesofensine 500mcg (30 Capsules)
Adipotide (FTPP) 10mg
AICAR 50mg
AOD9604 6mg
ARA-290 16mg
Bronchogen 20mg
B7-33 6mg
Cardiogen 20mg
Cartalax 20mg
Chonluten 20mg
Cortagen 20mg
Epithalon (Epitalon) 20mg
Epithalon (Epitalon) 50mg
FGL-S 10mg
Follistatin-315
Follistatin-344
FOXO4-DRI 10mg
GHK Basic 50mg
GHRH 5mg
GHRP-2 5mg
GHRP-2 10mg
GHRH (GH-Releasing Hormone)
Gonadorelin 10mg (GnRH)
Hexarelin 2mg
Hexarelin 5mg
Humanin 10mg
Livagen 20mg
LL-37 5mg (CAP-18)
MGF IGF-1 Ec 5mg
N-Acetyl Epithalon Amidate 20mg
N-Acetyl Selank Amidate 10mg
N-Acetyl Semax Amidate 30mg
NAD+ 100mg
NAD+ 750mg
Oxytocin 10mg (6000 IU)
Ovagen 20mg
Pancragen 20mg
PE-22-28
PEG-MGF (Pegylated MGF) 5mg
Pinealon 20mg
PNC-27 5mg
Prostamax 20mg
PT-141 (Bremelanotide) 3mg x 10 Vials
PT-141 (Bremelanotide) 10mg
P21 (P021) 5 mg
Selank 10mg
Semax 30mg
Sermorelin 2mg
Sermorelin 5mg
Sermorelin 15mg
TB-500 (Thymosin Beta-4) 2mg x 10 Vials
TB-500 (Thymosin Beta-4) 5mg
TB-500 (Thymosin Beta-4) 10mg
TB-500 Fragment (17-23)
Tesamorelin 2mg
Tesamorelin 5mg
Testagen 20mg
Thymagen 20mg
Thymosin Alpha-1 3mg
Thymosin Alpha-1 10mg
Thymalin 20mg
Thyrotropin TRH 20mg
Thyrotropin TRH 50mg
Triptorelin (GnRH) 2mg
Vesugen 20mg
Vesilute 20mg
Vilon 20mg
VIP 6 mg (Vasoactive Intestinal Peptide)
BPC157, TB500 10mg Blend
BPC157, TB500 20mg Blend
BPC157, TB500, GHK-Cu 30mg Glow Blend
BPC157, TB500, GHK-Cu 60mg Glow Blend
BPC157, TB500, GHK-Cu KPV 80mg Klow Blend
CJC1295, GHRP2 10mg Blend
CJC1295, GHRP6 10mg Blend
CJC1295, Hexarelin 10mg Blend
CJC1295, Ipamorelin 10mg Blend
Fragment, CJC1295, Ipamorelin Blend
Fragment, ModGRF, Ipamorelin Blend
ModGRF, GHRP2 10mg Blend
ModGRF, GHRP6 10mg Blend
ModGRF, Hexarelin 10mg Blend
ModGRF, Ipamorelin 10mg Blend
Sermorelin, Ipamorelin 10mg Blend
Sermorelin, GHRP6, GHRP2 Blend
Tesamorelin, CJC1295, Ipamorelin 12mg Blend
Tesamorelin, Ipamorelin 8mg Blend
IGF-1 LR3 1mg
IGF-1 LR3 Receptor 100mcg
IGF-1 LR3 Receptor Grade 1mg
MGF IGF-1 Ec 5mg
Melanotan 1 (10mg) (Melanotan)
Melanotan 2 (10mg) (Melanotan II)
Melanotan 2 (3mg) (Melanotan II)
PT-141 (10mg) (Bremelanotide)
PT-141 (3mg) (Bremelanotide)
Bronchogen 20mg
Cardiogen 20mg
Cartalax 20mg
Chonluten 20mg
Cortagen 20mg
Epithalon (Epitalon) 20mg
Epithalon (Epitalon) 50mg
Livagen 20mg
N-Acetyl Epithalon Amidate 20mg
Ovagen 20mg
Pancragen 20mg
Pinealon 20mg
Prostamax 20mg
Testagen 20mg
Thymagen 20mg
Vesugen 20mg
Vesilute 20mg
Vilon 20mg
Acetyl Hexapeptide-3 (Argireline)
AHK (Tripeptide-3)
AHK-Cu (Copper Peptide)
Decapeptide-12
GHK Basic 200mg (Tripeptide-1)
GHK-Cu 200mg (Copper Peptide)
GHK-Cu 500mg (Copper Peptide)
GHK-Cu 1000mg (Copper Peptide)
Matrixyl (palmitoyl pentapeptide-3)
Melanostatin DM
Nonapeptide-1
Pal-AHK
Pal-GHK (Palmitoyl Tripeptide-1)
Palmitoyl Dipeptide-6
Pentapeptide-18 (Leuphasyl)
Rigin (Palmitoyl Tetrapeptide-7)
SNAP-8 200mg
Syn-AKE
Syn-Coll (Palmitoyl Tripeptide-5)
Tripeptide-29 (Collagen peptide)
Vialox (Pentapeptide-3V)
Chemical Properties
Description
COA / HPLC / MS
Chemical Properties
Description
COA / HPLC / MS
Chemical Properties
Description
COA / HPLC / MS
Overview
Biochemical Characteristics
Research Applications
Pathway / Mechanistic Context
Form & Analytical Testing
RUO Disclaimer
Overview
Biochemical Characteristics
Research Applications
Pathway / Mechanistic Context
Form & Analytical Testing
RUO Disclaimer
Overview
Biochemical Characteristics
Research Applications
Pathway / Mechanistic Context
Form & Analytical Testing
RUO Disclaimer
Overview
CJC-1295 without DAC is a 30-amino acid tetrasubstituted GHRH analog designed to stimulate endogenous growth hormone secretion with intermediate half-life compared to both native GHRH and DAC-conjugated variants. The peptide provides sustained GHRH effects with dosing intervals of 2-3 times weekly. CJC-1295 no DAC is extensively studied for its potential in supporting growth hormone production, lean mass development, and metabolic function with balanced dosing frequency and GH axis stimulation. Research indicates the peptide activates GHRH receptor pathways, promoting endogenous growth hormone release with sustained biological activity lasting 24-30 hours per injection. CJC-1295 no DAC represents a valuable research tool for investigating intermediate-duration growth hormone signaling, metabolic adaptation, and therapeutic approaches to GH deficiency and age-related metabolic decline.
Overview
CJC-1295 without DAC is a 30-amino acid tetrasubstituted GHRH analog designed to stimulate endogenous growth hormone secretion with intermediate half-life compared to both native GHRH and DAC-conjugated variants. The peptide provides sustained GHRH effects with dosing intervals of 2-3 times weekly. CJC-1295 no DAC is extensively studied for its potential in supporting growth hormone production, lean mass development, and metabolic function with balanced dosing frequency and GH axis stimulation. Research indicates the peptide activates GHRH receptor pathways, promoting endogenous growth hormone release with sustained biological activity lasting 24-30 hours per injection. CJC-1295 no DAC represents a valuable research tool for investigating intermediate-duration growth hormone signaling, metabolic adaptation, and therapeutic approaches to GH deficiency and age-related metabolic decline.
Overview
CJC-1295 without DAC is a 30-amino acid tetrasubstituted GHRH analog designed to stimulate endogenous growth hormone secretion with intermediate half-life compared to both native GHRH and DAC-conjugated variants. The peptide provides sustained GHRH effects with dosing intervals of 2-3 times weekly. CJC-1295 no DAC is extensively studied for its potential in supporting growth hormone production, lean mass development, and metabolic function with balanced dosing frequency and GH axis stimulation. Research indicates the peptide activates GHRH receptor pathways, promoting endogenous growth hormone release with sustained biological activity lasting 24-30 hours per injection. CJC-1295 no DAC represents a valuable research tool for investigating intermediate-duration growth hormone signaling, metabolic adaptation, and therapeutic approaches to GH deficiency and age-related metabolic decline.
Biochemical Characteristics
CJC-1295 no DAC is a 30-amino acid GHRH analog with four amino acid modifications (tetrasubstituted), with molecular weight approximately 3,645 Da. The peptide lacks the drug affinity complex (DAC) modification, providing intermediate biological half-life between native GHRH and DAC-conjugated variants. The peptide is water-soluble and demonstrates excellent stability across physiological pH ranges (6.5–8.0). CJC-1295 no DAC exhibits extended biological half-life of approximately 24-30 hours due to amino acid substitutions providing resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and other peptidases. Cellular uptake occurs through GHRH receptor binding on pituitary somatotroph cells. The peptide distributes throughout pituitary tissue where growth hormone regulation occurs.
Biochemical Characteristics
CJC-1295 no DAC is a 30-amino acid GHRH analog with four amino acid modifications (tetrasubstituted), with molecular weight approximately 3,645 Da. The peptide lacks the drug affinity complex (DAC) modification, providing intermediate biological half-life between native GHRH and DAC-conjugated variants. The peptide is water-soluble and demonstrates excellent stability across physiological pH ranges (6.5–8.0). CJC-1295 no DAC exhibits extended biological half-life of approximately 24-30 hours due to amino acid substitutions providing resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and other peptidases. Cellular uptake occurs through GHRH receptor binding on pituitary somatotroph cells. The peptide distributes throughout pituitary tissue where growth hormone regulation occurs.
Biochemical Characteristics
CJC-1295 no DAC is a 30-amino acid GHRH analog with four amino acid modifications (tetrasubstituted), with molecular weight approximately 3,645 Da. The peptide lacks the drug affinity complex (DAC) modification, providing intermediate biological half-life between native GHRH and DAC-conjugated variants. The peptide is water-soluble and demonstrates excellent stability across physiological pH ranges (6.5–8.0). CJC-1295 no DAC exhibits extended biological half-life of approximately 24-30 hours due to amino acid substitutions providing resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) and other peptidases. Cellular uptake occurs through GHRH receptor binding on pituitary somatotroph cells. The peptide distributes throughout pituitary tissue where growth hormone regulation occurs.
Research Applications
Growth Hormone Stimulation Investigation of CJC-1295 no DAC-induced enhancement of endogenous growth hormone release with intermediate duration. Lean Mass Development Assessment of GH-dependent increase in muscle protein synthesis and lean body mass accumulation. Metabolic Rate Enhancement Study of improvements in metabolic rate, energy expenditure, and metabolic flexibility. Body Composition Improvement Investigation of improvements in lean-to-fat mass ratio and reduction in adiposity. Age-Related GH Decline Assessment of restoration of GH secretion in aging models and potential benefits in age-related somatopause. Physical Performance & Recovery Study of improvements in strength, power output, and exercise capacity through GH enhancement. Bone Density Support Investigation of support for bone remodeling and improvement in bone mineral density.
Research Applications
Growth Hormone Stimulation Investigation of CJC-1295 no DAC-induced enhancement of endogenous growth hormone release with intermediate duration. Lean Mass Development Assessment of GH-dependent increase in muscle protein synthesis and lean body mass accumulation. Metabolic Rate Enhancement Study of improvements in metabolic rate, energy expenditure, and metabolic flexibility. Body Composition Improvement Investigation of improvements in lean-to-fat mass ratio and reduction in adiposity. Age-Related GH Decline Assessment of restoration of GH secretion in aging models and potential benefits in age-related somatopause. Physical Performance & Recovery Study of improvements in strength, power output, and exercise capacity through GH enhancement. Bone Density Support Investigation of support for bone remodeling and improvement in bone mineral density.
Research Applications
Growth Hormone Stimulation Investigation of CJC-1295 no DAC-induced enhancement of endogenous growth hormone release with intermediate duration. Lean Mass Development Assessment of GH-dependent increase in muscle protein synthesis and lean body mass accumulation. Metabolic Rate Enhancement Study of improvements in metabolic rate, energy expenditure, and metabolic flexibility. Body Composition Improvement Investigation of improvements in lean-to-fat mass ratio and reduction in adiposity. Age-Related GH Decline Assessment of restoration of GH secretion in aging models and potential benefits in age-related somatopause. Physical Performance & Recovery Study of improvements in strength, power output, and exercise capacity through GH enhancement. Bone Density Support Investigation of support for bone remodeling and improvement in bone mineral density.
Pathway / Mechanistic Context
GHRH Receptor Activation CJC-1295 no DAC binds and activates growth hormone-releasing hormone (GHRH) receptors on anterior pituitary somatotroph cells, triggering cAMP-dependent signaling cascades that enhance growth hormone synthesis and secretion. Growth Hormone Release GHRH receptor activation promotes GH synthesis in somatotroph cells and triggers pulsatile exocytosis of growth hormone into systemic circulation with physiological secretion patterns. DPP-4 Resistance The tetrasubstituted amino acid modifications of CJC-1295 no DAC provide resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation, extending half-life compared to native GHRH while avoiding need for DAC conjugation. IGF-1 Production Growth hormone released through CJC-1295 no DAC stimulation acts on hepatic and peripheral tissues to enhance insulin-like growth factor-1 production, mediating metabolic and anabolic effects. Lipolysis & Fat Mobilization GH released through CJC-1295 no DAC stimulation enhances lipolysis in adipose tissue through hormone-sensitive lipase activation, promoting fat mobilization and utilization. Somatostatin Feedback Regulation CJC-1295 no DAC-induced GH release provides negative feedback that modulates somatostatin (growth hormone-inhibiting hormone) secretion, maintaining homeostatic control of GH axis function.
Pathway / Mechanistic Context
GHRH Receptor Activation CJC-1295 no DAC binds and activates growth hormone-releasing hormone (GHRH) receptors on anterior pituitary somatotroph cells, triggering cAMP-dependent signaling cascades that enhance growth hormone synthesis and secretion. Growth Hormone Release GHRH receptor activation promotes GH synthesis in somatotroph cells and triggers pulsatile exocytosis of growth hormone into systemic circulation with physiological secretion patterns. DPP-4 Resistance The tetrasubstituted amino acid modifications of CJC-1295 no DAC provide resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation, extending half-life compared to native GHRH while avoiding need for DAC conjugation. IGF-1 Production Growth hormone released through CJC-1295 no DAC stimulation acts on hepatic and peripheral tissues to enhance insulin-like growth factor-1 production, mediating metabolic and anabolic effects. Lipolysis & Fat Mobilization GH released through CJC-1295 no DAC stimulation enhances lipolysis in adipose tissue through hormone-sensitive lipase activation, promoting fat mobilization and utilization. Somatostatin Feedback Regulation CJC-1295 no DAC-induced GH release provides negative feedback that modulates somatostatin (growth hormone-inhibiting hormone) secretion, maintaining homeostatic control of GH axis function.
Pathway / Mechanistic Context
GHRH Receptor Activation CJC-1295 no DAC binds and activates growth hormone-releasing hormone (GHRH) receptors on anterior pituitary somatotroph cells, triggering cAMP-dependent signaling cascades that enhance growth hormone synthesis and secretion. Growth Hormone Release GHRH receptor activation promotes GH synthesis in somatotroph cells and triggers pulsatile exocytosis of growth hormone into systemic circulation with physiological secretion patterns. DPP-4 Resistance The tetrasubstituted amino acid modifications of CJC-1295 no DAC provide resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation, extending half-life compared to native GHRH while avoiding need for DAC conjugation. IGF-1 Production Growth hormone released through CJC-1295 no DAC stimulation acts on hepatic and peripheral tissues to enhance insulin-like growth factor-1 production, mediating metabolic and anabolic effects. Lipolysis & Fat Mobilization GH released through CJC-1295 no DAC stimulation enhances lipolysis in adipose tissue through hormone-sensitive lipase activation, promoting fat mobilization and utilization. Somatostatin Feedback Regulation CJC-1295 no DAC-induced GH release provides negative feedback that modulates somatostatin (growth hormone-inhibiting hormone) secretion, maintaining homeostatic control of GH axis function.
Preclinical Research Summary
CJC-1295 no DAC is supplied as sterile aqueous solution or lyophilized powder at concentrations of 1–10 mg/mL. Storage at 2–8°C; shelf-life 12–24 months for solutions, 24–36 months for lyophilized material. Analytical testing includes HPLC purity verification (≥95%), HPLC-MS molecular confirmation with tetrasubstituted amino acid verification, amino acid analysis, and microbial sterility/endotoxin testing. Bioassay verification of GHRH receptor agonist activity and GH-stimulatory effects available upon request. Certificate of Analysis provided with each lot.
Preclinical Research Summary
CJC-1295 no DAC is supplied as sterile aqueous solution or lyophilized powder at concentrations of 1–10 mg/mL. Storage at 2–8°C; shelf-life 12–24 months for solutions, 24–36 months for lyophilized material. Analytical testing includes HPLC purity verification (≥95%), HPLC-MS molecular confirmation with tetrasubstituted amino acid verification, amino acid analysis, and microbial sterility/endotoxin testing. Bioassay verification of GHRH receptor agonist activity and GH-stimulatory effects available upon request. Certificate of Analysis provided with each lot.
Preclinical Research Summary
CJC-1295 no DAC is supplied as sterile aqueous solution or lyophilized powder at concentrations of 1–10 mg/mL. Storage at 2–8°C; shelf-life 12–24 months for solutions, 24–36 months for lyophilized material. Analytical testing includes HPLC purity verification (≥95%), HPLC-MS molecular confirmation with tetrasubstituted amino acid verification, amino acid analysis, and microbial sterility/endotoxin testing. Bioassay verification of GHRH receptor agonist activity and GH-stimulatory effects available upon request. Certificate of Analysis provided with each lot.
RUO Disclaimer
RESEARCH USE ONLY (RUO) This product is intended exclusively for laboratory research and is not approved for clinical use or human/animal administration. Not manufactured for pharmaceutical use. Users assume responsibility for suitability determination, proper storage, safety compliance, and regulatory adherence. Institutional approval (IACUC, IRB) may be required. Information provided is for research reference only and does not constitute medical advice or therapeutic claims.
RUO Disclaimer
RESEARCH USE ONLY (RUO) This product is intended exclusively for laboratory research and is not approved for clinical use or human/animal administration. Not manufactured for pharmaceutical use. Users assume responsibility for suitability determination, proper storage, safety compliance, and regulatory adherence. Institutional approval (IACUC, IRB) may be required. Information provided is for research reference only and does not constitute medical advice or therapeutic claims.
RUO Disclaimer
RESEARCH USE ONLY (RUO) This product is intended exclusively for laboratory research and is not approved for clinical use or human/animal administration. Not manufactured for pharmaceutical use. Users assume responsibility for suitability determination, proper storage, safety compliance, and regulatory adherence. Institutional approval (IACUC, IRB) may be required. Information provided is for research reference only and does not constitute medical advice or therapeutic claims.
$
169 AUD
CJC-1295 NO DAC
We are committed to supporting all research customers with consistent standards and professional care.
Information
Buy Peptides
Peptide Capsules
Purchase Peptides
Peptide Blends
Bioregulators
IGF-1 Proteins
Cosmetic Peptides
Melanotan Peptides
Legal
Privacy Policy
Terms of use
Shipping & Payments
Reward Program Terms
Refunds & Returns
Accessibility Statement
Contact Us
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
© Standard BioLabs. All rights reserved.
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Peptide Sciences is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
We are committed to supporting all research customers with consistent standards and professional care.
Information
Buy Peptides
Peptide Capsules
Purchase Peptides
Peptide Blends
Bioregulators
IGF-1 Proteins
Cosmetic Peptides
Melanotan Peptides
Legal
Privacy Policy
Terms of use
Shipping & Payments
Reward Program Terms
Refunds & Returns
Accessibility Statement
Contact Us
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Peptide Sciences is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
© Standard BioLabs. All rights reserved.
We are committed to supporting all research customers with consistent standards and professional care.
Information
Buy Peptides
Peptide Capsules
Purchase Peptides
Peptide Blends
Bioregulators
IGF-1 Proteins
Cosmetic Peptides
Melanotan Peptides
Legal
Privacy Policy
Terms of use
Shipping & Payments
Reward Program Terms
Refunds & Returns
Accessibility Statement
Contact Us
Subscribe
Subscribe to stay updated at every moment about all our news and product drops.
Terms of Service
Refund Policy
Privacy Policy
Promotional Terms
© Standard BioLabs. All rights reserved.
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Standard BioLabs is a chemical supplier. Peptide Sciences is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.